Two researchers from Manchester University NHS Foundation Trust (MFT) have been named as winners in the Royal College of Physicians (RCP) and National Institute for Health Research (NIHR) Clinical Res
A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.
Unwell COVID-19 patients may be treated just as effectively with oxygen through a mask rather than Continuous Positive Airway Pressure (CPAP), according to a new study.
A 70-year-old woman, forced to live with cough since her 40s, is ‘excited’ to be the first person in the world to receive a potential new cough treatment.
Manchester University NHS Foundation Trust is opening themselves up to a three-month reflective assessment of their delivery of race equality in health research.